health.economictimes.indiatimes

Stelis Biopharma receives EU-GMP compliance certificate for two manufacturing facilities

The facilities (Unit 2) is a state-of-the-art manufacturing setup that leverages microbial and mammalian platforms for developing and commercialising biologics and biosimilars in multiple fill-finish ...
VCCircle

GIC-backed Syngene inks $88-mn deal to buy Stelis Biopharma’s unit

Syngene International Ltd, a drug research company backed by Singapore sovereign wealth fund GIC, is set to acquire Stelis Biopharma’s manufacturing unit in Bengaluru for Rs 702 crore (around $88 ...
India Infoline

Stelis Biopharma's flagship facility receives EIR from USFDA for Drug Products at its Bengaluru facility

Stelis Biopharma Limited, the biologics arm of Strides Pharma Science Limited, has announced that it received the Establishment Inspection Report (EIR) from U.S. Food and Drug Administration (USFDA) ...
India Infoline

Stelis Biopharmas flagship DP facility receives EIR from USFDA

Stelis Biopharma, an emerging biopharmaceutical Contract Development and Manufacturing Organization (CDMO) and the biologics arm of Strides Pharma Science today announced that it received the ...